Search - tctmd.com

Displaying 741 - 760 of 1346

Sort: Relevancy | Date

News Daily News

抗凝诊所在非华法林方案的时代的崭新作用

Todd Neale

March 01, 2016

News Daily News

Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina

Todd Neale

March 01, 2016

News Daily News

New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options

Todd Neale

March 01, 2016

News Daily News

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Michael O'Riordan

February 28, 2016

News Industry News

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

February 22, 2016

News Daily News

研究认为有数据支持针对患者风险而非 LDL 胆固醇目标进行治疗

Michael O'Riordan

February 15, 2016

News Daily News

Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues

Michael O'Riordan

February 15, 2016

Presentation JIM 2016

Optimal Duration of Oral Antiplatelet Therapy

Presenter: Dominick J. Angiolillo

February 11, 2016

Presentation JIM 2016

GP2b3a blockers:Back to the future

Presenter: Arnoud van ?t Hof

February 11, 2016

Presentation JIM 2016

Clinical Case: High risk ACS

Presenter: Giuseppe Tarantini

February 11, 2016

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI

Presenter: Dominick J. Angiolillo

February 09, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

L.A. McKeown

February 09, 2016

Presentation

Why are the data for Pretreatment Weak?

Presenter: Duane S. Pinto

February 08, 2016

Presentation

Timing of Clopidogrel Loading in US Practice

Presenter: Gregg W. Stone

February 08, 2016

News Daily News

Signs of Cardioprotection Seen in Acute STEMI Patients Receiving IV Beta-blocker Post-PCI

Caitlin E. Cox

February 03, 2016

News Daily News

Se Observan Signos de Cardioprotección en Pacientes STEMI Agudos que Reciben Beta-Bloqueadores Post-PCI

Caitlin E. Cox

February 03, 2016

News Daily News

PCI 后接受 IV β 受体阻滞剂的急性 STEMI 患者中观察到心肌保护迹象

Caitlin E. Cox

February 03, 2016

Presentation

BEAT-AMI: Randomized Control of Sympathetic Drive With Continuous IV Esmolol in Patients With Acute STEMI

Presenter: Fikret Er

February 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

News Daily News

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Michael O'Riordan

January 26, 2016

Advertisement

抗凝诊所在非华法林方案的时代的崭新作用

Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina

New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

研究认为有数据支持针对患者风险而非 LDL 胆固醇目标进行治疗

Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues

Optimal Duration of Oral Antiplatelet Therapy

GP2b3a blockers:Back to the future

Clinical Case: High risk ACS

Ticagrelor vs Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

Why are the data for Pretreatment Weak?

Timing of Clopidogrel Loading in US Practice

Signs of Cardioprotection Seen in Acute STEMI Patients Receiving IV Beta-blocker Post-PCI

Se Observan Signos de Cardioprotección en Pacientes STEMI Agudos que Reciben Beta-Bloqueadores Post-PCI

PCI 后接受 IV β 受体阻滞剂的急性 STEMI 患者中观察到心肌保护迹象

BEAT-AMI: Randomized Control of Sympathetic Drive With Continuous IV Esmolol in Patients With Acute STEMI

TCTMD’s Top 10 Most Popular Stories for January 2016

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content